-
1دورية أكاديمية
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
2دورية أكاديمية
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
3دورية أكاديمية
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
4
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
5صورة
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
6
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018 -
7
المؤلفون: Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
مصطلحات موضوعية: Medicine, Neuroscience, Developmental Biology, Cancer, Infectious Diseases, Virology, Computational Biology, vitamin k antagonists, vitamin k antagonist, routine clinical practice, recent cancer history, 9 8211, time users treated, bleeding ), death, european rivaroxaban post, 44 737 rivaroxaban,
+overall%22">xlink "> overall, +cohorts%22">xlink "> cohorts, among rivaroxaban users, crude incidence rates, december 2017 ), venous thromboembolism indication, %22">xlink ">, rivaroxaban users, venous thromboembolism, incidence rates, december 2017, vte indication, december 2018